# Relmada Therapeutics, Inc.: Form 8-K, filed Mar 9, 2020

- Company: [Relmada Therapeutics, Inc.](/companies/rlmd.md) (CIK 1553643)
- Form: 8-K
- Filed: 2020-03-09
- Accepted by EDGAR: Mar 9, 2020, 16:17 ET
- Period: 2020-03-06
- Accession: 0001213900-20-005746
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1553643/000121390020005746/ea119427-8k_relmadatherap.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1553643/000121390020005746/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1553643/000121390020005746/ea119427-8k_relmadatherap.htm

Filed Mar 9, 2020.
Source: SEC EDGAR, the filing index for accession 0001213900-20-005746. Last ingested by Listed: Nov 13, 2026, 15:42 ET. No prices; not investment advice.
